Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
IMMUNETHEP Logo
IMMUNETHEP Growth Score
76
CB Rank
84431
Heat Score
70
Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies
Founded
obfuscation
PrivateGrant Cantanhede, Coimbra, Portugal1-10 www.immunethep.com
Biotechnology
Medical
Pharmaceutical
Overview

IMMUNETHEP
Total Funding
obfuscation
Growth Score
76
Heat Score
70

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score76
-8 pts
in past quarter
Heat Score 70
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About IMMUNETHEP

CB Rank
84431
Immunethep is a biotech startup company that is developing broad coverage anti-bacterial immunotherapies
Founded
obfuscation
PrivateGrant Cantanhede, Coimbra, Portugal1-10 www.immunethep.com
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name Immunethep, S.A.
Operating Status Active
Company Type For Profit
Founders  Agostinho João Almeida, Bruno Santos, Hugo Ramos, João Ferreira, Pedro Madureira, Rafael Simão
About the Company

Immunethep is a biotechnology company focused on drug development for Immune System related pathologies. Immunethep is a spin-off from the University of Porto that uses its proprietary technology to address unmet medical needs. Immunethep discovered a novel mechanism used by different pathogenic bacteria to suppress host immune response. By

targeting this mechanism we are developing broad coverage anti-bacterial immunotherapies.

Phone Number +351231419042
Contact Email info@immunethep.com
Predictions & Insights

Growth Insight

See this Growth Insight
IMMUNETHEP is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

PNV (Multivalent Antibacterial Vaccine)
A vaccine targeting five bacteria: Staphylococcus aureus, Streptococcus pneumoniae, Klebsiella pneumoniae, Escherichia coli, and Streptococcus agalactiae (GBS), neutralizing bacterial GAPDH.
UNImAb (Multivalent Antibacterial Monoclonal Antibodies)
Therapeutic monoclonal antibodies targeting the same bacteria as PNV, focusing on treating infections by neutralizing bacterial GAPDH.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant
obfuscation
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
1
obfuscation
PACE-AMRGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
PACE-AMR Logo
PACE-AMR
Yes
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
—
PACE-AMR Logo
PACE-AMR
Yes
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
—
PACE-AMR Logo
PACE-AMR
Yes
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
—
PACE-AMR Logo
PACE-AMR
Yes
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
—
PACE-AMR Logo
PACE-AMR
Yes
Grant - IMMUNETHEP Logo
Grant - IMMUNETHEP
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 4 Board Members and Advisors 1 Contacts 4

Employee Profiles

Board Members and Advisors

News

News and Press

News•Mar 23, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

615
126.1%
 in past month

IT Spend

$285.1KThis year, IMMUNETHEP is projected to spend $285.1K on IT, according to Aberdeen.

Active Website Tech Count

4IMMUNETHEP is actively using 4 technologies for its website, according to BuiltWith. These include Viewport Meta, Google Maps, and  CommonCrawl Top 5m.

Total IP

2The intellectual property of IMMUNETHEP includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is IMMUNETHEP's headquarters? IMMUNETHEP is located in Cantanhede, Coimbra, Portugal.Who invested in IMMUNETHEP? IMMUNETHEP has 5 investors including PACE-AMR and  European Innovation Council.When was the last funding round for IMMUNETHEP? IMMUNETHEP closed its last funding round on
obfuscation
from a Grant round.Who are IMMUNETHEP's competitors? Alternatives and possible competitors to IMMUNETHEP may include Pfizer, Sanofi, and  Valneva.How much funding has IMMUNETHEP raised to date? IMMUNETHEP has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(882d4b2 1)
|